Related Experiment Video
Updated: Jun 20, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Micro-calpain regulates caspase-dependent and apoptosis inducing factor-mediated caspase-independent apoptotic
1MOE Key Laboratory of Laser Life Science and Institute of Laser Life Science, South China Normal University, Guangzhou, China.
Abstract:
Cisplatin, an effective anticancer agent, can induce tumor cell apoptosis via caspase-dependent and-independent pathways. However, the precise mechanism that regulates the pathways remains unclear. In this study, we showed that micro-calpain mediated both caspase-dependent and-independent pathways during cisplatin-induced apoptosis in human lung adenocarcinoma cells. After cisplatin treatment, calpain activation, as measured by a fluorescent substrate, was an early event, taking place well before apoptosis inducing factor (AIF) release and caspase-9/-3 activation. Confocal imaging of cells transfected with AIF-GFP demonstrated that AIF release occurred about 9 hr after cisplatin treatment. The increase of micro-calpain activity proved to be a crucial event in the apoptotic machinery, as demonstrated by the significant protection of cell death in samples suppressed the endogenous micro-calpain expression level, as well as cotreated with the calpain inhibitors, calpeptin and PD150606. Inhibition of mu-calpain not only significantly reduced caspase-9/-3 activities but also completely blocked AIF redistribution. Our study also showed that endogenous mitochondrial micro-calpain could directly induce the truncation and release of AIF, while caspases and cathepsins were not necessary for this process. In conclusion, the study demonstrated that activation of micro-calpain played an essential role in regulating both caspase-dependent and AIF-mediated caspase-independent apoptotic pathways in cisplatin-induced apoptosis.
Insights
Micro-calpain activation is crucial for cisplatin-induced apoptosis in lung cancer cells. It regulates both caspase-dependent and apoptosis-inducing factor (AIF) release pathways, offering potential therapeutic targets.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Cisplatin is a key chemotherapy drug inducing apoptosis through caspase-dependent and -independent routes.
- The exact regulatory mechanisms governing these apoptotic pathways remain incompletely understood.
Purpose of the Study:
- To elucidate the role of micro-calpain in cisplatin-induced apoptosis in human lung adenocarcinoma cells.
- To determine if micro-calpain regulates both caspase-dependent and caspase-independent apoptotic pathways.
Main Methods:
- Assessed calpain activation using fluorescent substrates post-cisplatin treatment.
- Utilized confocal imaging to track apoptosis-inducing factor (AIF) release.
- Investigated the effect of suppressing micro-calpain expression and using calpain inhibitors (calpeptin, PD150606) on cell death and caspase activity.
Main Results:
- Micro-calpain activation occurred early, preceding AIF release and caspase activation.
- Inhibition of micro-calpain significantly protected cells from death, reduced caspase activity, and blocked AIF redistribution.
- Mitochondrial micro-calpain was shown to directly trigger AIF truncation and release, independent of caspases or cathepsins.
Conclusions:
- Micro-calpain activation is essential for regulating both caspase-dependent and AIF-mediated caspase-independent apoptosis induced by cisplatin.
- Micro-calpain represents a critical regulator and potential therapeutic target in cisplatin-induced apoptotic signaling.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
MAPK Signaling Cascades

